GlassScriptPhysician profile
Christopher Lee Cullum
NPI 1275988578
$15,105.44
in general payments reported to CMS, 2019-2025
16 companies · $2,519 in 2025
The $2,519 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,176 · 2020: $456 · 2021: $1,902 · 2022: $4,278 · 2023: $3,894 · 2024: $879 · 2025: $2,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,882 · Travel and Lodging: $2,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,882.11 |
| Travel and Lodging | $2,411.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,920.29 | 2019-2025 | Prophecy, Invision, Inbone |
| Legacy Ortho LLC | $2,536.03 | 2022-2024 | |
| Smith+Nephew, INC. | $539.83 | 2019-2025 | Stravix, Grafix, Collagenase Santyl |
| Integra Lifesciences Corporation | $430.10 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $374.01 | 2020-2023 | Krystexxa |
| Imperative Care, INC | $290.24 | 2023 | Prodigy Catheter |
| Paragon 28, INC. | $215.53 | 2019-2020 | |
| Bone Support INC. | $132.38 | 2025 | Cerament G, Ceramentbone Void Filler |
| Heron Therapeutics, INC. | $127.86 | 2021 | |
| Zimmer Biomet Holdings, INC. | $126.74 | 2019 | |
| Amgen INC. | $120.11 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $116.08 | 2022-2025 | Accelstim |
| Kci USA, INC. | $73.74 | 2019 | |
| Kuros Biosciences USA, INC | $48.33 | 2025 | Magnetos |
| Wright Medical Technology, INC. | $29.26 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $24.91 | 2025 | Apligraf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cullum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.